Clinical Trial Update: Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis

View source ↗

Summary

This clinical trial update evaluates the effects of dalfampridine (Fampyra) on gait, vision, cognition, fatigue, and bladder function in people with Multiple Sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampyra (fampridine)

Snippet

Sponsor: Vestre Viken Hospital Trust | Conditions: Multiple Sclerosis, EDSS 4-7 | Status: UNKNOWN